We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

mHealth Spectroscopy Measures Hemoglobin Optically

By HospiMedica International staff writers
Posted on 08 Jun 2020
A novel smartphone-based technique helps assess blood hemoglobin (Hgb) and blood disorders without drawing blood, claims a new study.

Developed at Purdue University (Lafayette, IN, USA), Vanderbilt University (Nashville, TN, USA), and Moi University (Nairobi, Kenya), the smartphone app is based on spectral super-resolution (SSR) spectroscopy, which transforms the built-in camera of a smartphone into a hyperspectral imager, without the need for hardware modifications or accessories. More...
The Hgb measurements are based on statistical learning of SSR of the eyelids, and reconstruction of the detailed spectra from the camera’s three color RGB data. To perform an Hgb measurement, the patient pulls down the inner eyelid to expose the small blood vessels underneath.

A healthcare professional then uses the smartphone app to take pictures of the inner eyelids. The SSR then extracts the detailed spectral information from the camera's images and a computational algorithm quantifies Hgb content from the data. The mobile app also includes features designed to stabilize image quality and synchronize the smartphone flashlight so as to obtain consistent images. The inner eyelid was selected as the sensing site because microvasculature is easily visible there, and it is not affected by skin color, which eliminates the need for any personal calibrations.

With the aid of a randomly selected group of 138 patients who had conventional blood tests at the Moi University Teaching and Referral Hospital, the researchers first trained the algorithm, and then tested the mobile health app with the remaining 15 volunteers. The results showed that the prediction errors for the smartphone technique were within 5-10% of those measured with clinical laboratory blood tests. They now plan to use the mobile health tool to assess nutritional status, anemia, and sickle cell disease. The study was published in the June 2020 issue of Optica.

“This new technology could be very useful for detecting anemia, which is characterized by low levels of blood hemoglobin. This is a major public health problem in developing countries, but can also be caused by cancer and cancer treatments,” said senior author Professor Young Kim, PhD, of Purdue University. "The COVID-19 pandemic has greatly increased awareness of the need for expanded mobile health and telemedicine services.”

Related Links:
Purdue University
Vanderbilt University
Moi University



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
image: Principles of SMEAR-ULM. (Lai, Y., Argüello, A.N., Liu, M. et al., Nature Sensors (2026). DOI: 10.1038/s44460-026-00078-4)

“Intelligent Tattoo” Method Detects Early Melanoma Signals

Melanoma is a lethal skin cancer in which earlier detection drives better outcomes. Current evaluation relies on visual inspection followed by biopsy, which can miss nascent lesions and lead to unnecessary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.